Related by context. All words. (Click for frequent words.) 76 Thromboembolic 76 Ischemic Stroke 75 Ischaemic 75 Non Alcoholic Fatty 75 Metastases 75 Thrombotic 75 Leukemias 74 Skeletal Muscle 74 Mouse Model 74 Fracture Risk 74 Hypotension 74 Chronic Pelvic Pain 74 Chronic Heart Failure 74 complement inhibitor eculizumab 74 Ventricular Tachycardia 74 Radiofrequency Ablation 74 Catheter Associated 74 Chronic Sinusitis 73 Myocardial 73 Drug Prevents 73 Treating Chronic 73 Acute Renal Failure 73 Intracerebral Hemorrhage 73 Atypical Hemolytic Uremic Syndrome 73 Autoantibodies 73 Myocardial Ischemia 73 Knee Osteoarthritis 73 Patients Receiving 73 Juvenile Idiopathic Arthritis 73 Peripheral Arterial 73 Atherosclerotic 73 Minimally Invasive Treatment 73 Overactive Bladder 73 Septic Shock 73 Esophageal 73 Disease Progression 73 Arrhythmias 73 Signaling Pathway 73 Thromboembolism 73 Gene Mutation 73 Diabetic Neuropathy 73 Coronary Arteries 73 Neoplasms 72 Neovascular Age Related Macular 72 Shows Promise Against 72 Patients Treated With 72 Infarction 72 Malignant Glioma 72 Brain Metastases 72 Meets Primary Endpoint 72 Clinical Outcome 72 Renal Artery 72 Fungal Infections 72 Genetic Markers 72 Adjuvant Chemotherapy 72 Prospective Randomized 72 Renal Cell Carcinoma 72 Kidney Function 72 leiomyomas 72 Patients Undergoing 72 Cognitive Impairment 72 Effective Treatments 72 Chronic Prostatitis 72 Rheumatoid Arthritis Patients 72 Coronary Artery 72 Hypercholesterolemia 72 Peptic Ulcer 72 Prolongs Survival 72 Progenitor Cells 72 Left Ventricular 72 Genes Linked 72 Fibrosis 72 Squamous Cell Carcinoma 72 Bone Metastases 72 Endometrial Cancer 72 Electrical Stimulation 72 Subarachnoid hemorrhage 72 Predict Risk 72 Genetic Variation 72 Lowers Risk 72 Improves Outcomes 72 Allogeneic 72 Antitumor Activity 72 Inhaled Corticosteroids 72 Cardiotoxicity 72 Non Alcoholic Steatohepatitis 72 Iron Overload 72 Prophylactic Treatment 72 Hematopoietic 72 Mucositis 72 Intracranial 71 Oral Fingolimod 71 Diabetic Foot Ulcer 71 Hepatic 71 Allergic Rhinitis 71 Insulin Sensitivity 71 Elderly Patients 71 Chemotherapy Induced 71 Diabetic Foot Ulcers 71 Decitabine 71 metastatic malignant 71 Subtypes 71 Idiopathic 71 Ovarian Cancers 71 Endothelial 71 Relapsing Multiple Sclerosis 71 Atopic Dermatitis 71 Vertebral Fractures 71 ST Segment Elevation 71 Infarct 71 Radiation Induced 71 Gastric Cancer 71 Intracerebral 71 Heart Failure Patients 71 Lymphoid 71 Stenosis 71 Liver Failure 71 Hyperlipidemia 71 Hyperparathyroidism 71 Prognostic Factors 71 Polyneuropathy 71 Renal Function 71 Embolic 71 Endometrial 71 Hypertensive Patients 71 Levels Linked 71 Cognitive Deficits 71 Subgroup Analysis 71 Asymptomatic 71 Neuroprotection 71 Gene Linked 71 Carcinomas 71 Malignancies 71 Chronic Renal Failure 71 Parkinson Disease PD 71 Endothelial Function 71 Ischemia 71 Papillary 71 Diabetic Nephropathy 71 Stress Induced 71 Myocardial Infarction MI 71 Paroxysmal 71 Carotid Stenting 71 Relapsing Remitting Multiple Sclerosis 71 Chemotherapy induced 71 Adjuvant Treatment 71 Iron Deficiency 70 Valvular 70 Liver Injury 70 Microvascular 70 Severe Sepsis 70 ACE Inhibitors 70 Novel Oral 70 Refractory Hodgkin Lymphoma 70 Neuroprotective Effects 70 Immune Responses 70 AA Amyloidosis 70 Hypertrophic 70 Critically Ill Patients 70 Progressive Multifocal Leukoencephalopathy 70 Critical Limb Ischemia 70 Acute Myocardial Infarction 70 Angioedema 70 Dual Antiplatelet Therapy 70 Hepatocellular Carcinoma 70 Cutaneous 70 Dendritic Cells 70 Critical Limb Ischemia CLI 70 Diastolic Heart Failure 70 Statistically Significant 70 Unstable Angina 70 Benign Prostatic Hyperplasia 70 Rheumatoid 70 Hematologic 70 Autoimmune Disorders 70 Improves Survival 70 Thiazolidinediones 70 Acute Coronary 70 Nilotinib 70 Primary Hypercholesterolemia 70 Cerebellar 70 Often Misdiagnosed 70 Mitral Regurgitation 70 Vertebral Compression Fractures 70 Microalbuminuria 70 Breast Cancers 70 Investigational Treatment 70 Severe Asthma 70 Restenosis 70 Myelofibrosis 70 Adjunctive 70 Acute Ischemic Stroke 70 Stress Urinary Incontinence 70 Growth Hormone Deficiency 70 Glucocorticoid 70 Lung Injury 70 Unstable angina 70 Risk Stratification 70 Oral Mucositis 70 Premenopausal Women 70 Breast Cancer Recurrence 70 Hemorrhagic 70 Bone Fractures 70 Chronic HCV 70 Tumor Growth 70 antiphospholipid syndrome 70 cystic fibrosis chronic pancreatitis 70 Immune Mediated 70 Chronic Myelogenous Leukemia 70 Esophagitis 70 NIDDM 70 Occlusive Disease 70 Acute Coronary Syndrome 70 Hormone Receptor Positive 70 ST Elevation Myocardial 70 Thyroid Hormone 70 Invasive Breast Cancer 70 Appears Safe 70 Improve Survival 70 Migraine Headaches 70 Venous Thromboembolism 70 Resistant Hypertension 70 Secondary Hyperparathyroidism 70 Hypertrophy 70 Postmenopausal Women 70 Aortic Stenosis 70 Clinical Relevance 70 Thrombus 70 Autoimmune Disease 70 Irritable Bowel 70 HeFH 70 Replacement Therapy 70 Randomized Study 70 Reduced Risk 70 Metastatic Prostate Cancer 70 Catheter Ablation 70 CYT# potent vascular disrupting 70 Malignant Melanoma 70 Pooled Analysis 70 Nonalcoholic Fatty Liver Disease 70 Hypertriglyceridemia 70 Cardiovascular Events 69 Protein Linked 69 Proteinuria 69 Pulmonary Arterial Hypertension 69 Inflammatory Markers 69 Non Invasive Treatment 69 Prostatic 69 Myocardial infarction 69 Delayed Graft Function 69 Androgen 69 Hepatic Encephalopathy 69 Meningiomas 69 Statin Therapy 69 Patellofemoral 69 Drug Shows Promise 69 Angiogenic 69 Prevent Heart 69 Increased Mortality 69 Epidermal Growth Factor Receptor 69 Cardiovascular Disease Risk 69 Dehydrogenase 69 Is Well Tolerated 69 Exacerbation 69 Bronchiectasis 69 Basal Cell 69 occlusive disease 69 STRIDE PD 69 Fibrinogen 69 Orthostatic Hypotension 69 Pulmonary Artery 69 Arrhythmogenic 69 Soft Tissue Sarcoma 69 Gene Variant 69 Dyslipidemia 69 Breast Cancer Cells 69 Obese Patients 69 Unresectable 69 Organ Rejection 69 Patients Treated 69 HER2 Positive Breast Cancer 69 Acute Heart Failure 69 Neurogenic 69 Reperfusion Injury 69 Phase 2b Clinical Trial 69 Surgical Treatment 69 Dysplasia 69 Premature Aging 69 Myelodysplastic Syndrome 69 pulmonary alveolar 69 Coronary Artery Bypass Graft 69 vitreous floaters 69 Thrombolysis 69 Diabetic Patients 69 Intravascular 69 Cell Transplants 69 Serious Infections 69 Genes Associated 69 Preclinical Models 69 Beta Blocker 69 diabetes mellitus DM 69 Urinary tract 69 Demonstrates Positive 69 Novel Mechanism 69 Hormone Refractory Prostate Cancer 69 Preterm Delivery 69 Slows Progression 69 Neuropathic 69 Neuronal 69 See CLINICAL PHARMACOLOGY 69 Breast Tissue 69 Hyperkalemia 69 Effectively Treats 69 intracerebral 69 Treatment Shows Promise 69 Panic Disorder 69 Portal Hypertension 69 Advanced Renal Cell 69 Shows Promising 69 Sezary syndrome 69 Premature Infants 69 Sjogren Syndrome 69 Myelodysplastic Syndromes 69 Hepatotoxicity 69 Localized Prostate Cancer 69 Anthracycline 69 Innate Immune 69 Gene Variants 69 Fibroblast 69 kidney urologic 69 Hippocampal 69 Breast Tumors 69 cardiac conduction 69 Breast Cancer Stem Cells 69 Therapy Improves 69 Patients Suffering 69 dual endothelin receptor antagonist 69 Kidney Stones 69 Lymphocytic 69 Glomerular 69 CP CPPS 69 Spinal Fusion 69 Metastatic Renal Cell Carcinoma 69 Antidepressants Linked 69 Acute Decompensated Heart Failure 69 Hemolysis 69 Advanced Melanoma 69 Acute Coronary Syndromes 69 Malignancy 69 Tyrosine Kinase Inhibitor 69 Antiangiogenic 69 B Cell Lymphoma 69 JAK2 enzyme 69 Endocarditis 69 hemorrhagic cerebrovascular events 69 Oncogenic 69 Genetic Mutation 69 Embolization 69 Adenoma 69 Autoimmune Diseases 68 cytomegalovirus infection 68 Kidney Failure 68 Pancreatic 68 Suicidality 68 MR Angiography 68 Prognostic Value 68 Sleep Disturbances 68 Combo Therapy 68 Beta Amyloid 68 Adenomas 68 Precancerous 68 cerebral vasospasm 68 Albuminuria 68 Cardiac Resynchronization Therapy 68 Controlled Trial 68 Arteriosclerosis 68 Angiographic 68 erythematosus 68 Aortic Valve 68 Recurrent Breast Cancer 68 Hemorrhagic Stroke 68 Insulin Resistance 68 vWD 68 Neovascularization 68 Etiology 68 Novel Inhibitor 68 Afib 68 arterial calcification 68 Unfractionated Heparin 68 SSc 68 CT Angiography 68 Sipuleucel T 68 Peripheral Vascular Disease 68 Chronic Inflammatory 68 Pioglitazone 68 Immunosuppression 68 Osteoporosis Drugs 68 Phase IIa Clinical Trial 68 Inflammatory Diseases 68 Exacerbations 68 Inflammatory Pain 68 ABCB1 68 Clotting 68 Polymorphisms 68 optic neuropathy 68 primary hyperparathyroidism 68 Reduces Mortality 68 recurrent glioblastoma multiforme 68 PLX STROKE targeting 68 Therapy Reduces 68 Chronic Constipation 68 Dilated Cardiomyopathy 68 Cholesterol Lowering Drug 68 metastatic neuroendocrine tumors 68 Erythropoietic therapies may 68 Myoblast 68 chronic thromboembolic pulmonary 68 Systemic Sclerosis 68 Uterine Cancer 68 artery stenosis 68 Bloodstream Infections 68 Nonspecific 68 Schizoaffective Disorder 68 Renal Impairment 68 Slow Progression 68 proliferative retinopathy 68 Hemorrhagic stroke 68 Breast Cancer Metastasis 68 Long Term Survival 68 Aggressive Prostate Cancer 68 Invasive Fungal Infections 68 Treated Patients 68 Radiofrequency Ablation RFA 68 hepatic cirrhosis 68 Subclinical 68 Periodontitis 68 Artery Disease 68 Adult Stem Cell Therapy 68 Castration Resistant Prostate Cancer 68 Adenoviral 68 Acute Exacerbations 68 Pelvic Organ Prolapse 68 Tumor Suppressor 68 Complicated Skin 68 Polycystic ovary syndrome PCOS 68 Sustained Reduction 68 Cognitive Decline 68 Preclinical Study 68 Etanercept 68 Androgen Deprivation Therapy 68 Newly Diagnosed Multiple Myeloma 68 colorectal carcinoma 68 atrophic gastritis 68 Anti Tumor Activity 68 symptomatic intracranial 68 hyperprolactinemia 68 Combination Treatment 68 Diffuse Large B 68 Genetic Variations 68 Calcification 68 Estrogen Receptor 68 Hypothalamic 68 Metabolic Disorder 68 Transplant Rejection 68 Phase 2b Study 68 Drug Resistant 68 Renal Cancer 68 diabetic kidney 68 Peritonitis 68 Heart Transplant Recipients 68 Prostate Cancer Patients 68 Low Dose 68 Genes Identified 68 Muscle Wasting 68 Macrophage 68 Venous Thrombosis 68 Intracranial Aneurysms 68 Atrial 68 Aurora Kinase 68 Myelodysplastic Syndrome MDS 68 Comorbidities 68 Demonstrates Efficacy 68 Thrombocytopenia 68 Inhaled Nitric Oxide 68 Immunologic 68 Virus Infection 68 Eye Diseases 68 Autologous Stem Cell Transplantation 68 Peripheral Artery Disease 68 Antithrombin 68 Hip Fractures 68 Resection 68 Cognitive Problems 68 Recurrent Stroke 68 hypoperfusion 68 ischemia induced 68 Myocardial Infarction 68 Eculizumab 68 familial amyloidotic polyneuropathy FAP 68 Minimally Invasive Procedure 68 urolithiasis 68 Mouse Models 68 Angiotensin II 68 Aortic Aneurysm 68 Female Sexual Arousal 68 Aortic 68 Proves Effective 68 Epileptic Seizures 68 Successfully Treated 68 INTEGRILIN R 68 Lupus Nephritis 68 Lung Cancer Survival 68 Blood Clot Risk 68 Diabetic nephropathy 68 Epithelial 68 Chronic Myeloid Leukemia 68 peripheral arterial occlusive disease 68 Lipid Levels 68 Phase 2a Clinical Trial 68 Malformations 68 underlying vasculopathy 68 occlusion CRVO 68 Capsular 68 Transdermal Patch 68 Urinary Incontinence 68 Successfully Treats 68 Interferon Beta 67 Aneurysm Repair 67 Pediatric Patients 67 Peripheral Blood 67 capillary leak 67 Anticoagulants 67 dilated cardiomyopathy DCM 67 Cell Adhesion 67 Uric Acid 67 Metastatic Colorectal Cancer 67 pulmonary hypertension PH 67 haematologic 67 Abdominal Fat 67 Tumor Response 67 myopathies 67 Endothelial Cells 67 Modulates 67 ORLive Presents 67 Therapeutic Effects 67 Hyperuricemia 67 Abciximab 67 Neoadjuvant Chemotherapy 67 Acidosis 67 Cutaneous T 67 Cholesterol Levels 67 Gene Variation 67 Aortic stenosis 67 cytopenias 67 Patency 67 Reduces Pain 67 Cardiac Function 67 Tiotropium 67 hyperhomocysteinemia 67 Cytotoxic 67 coagulopathy 67 C Reactive Protein 67 Genetic Variant 67 Natalizumab 67 Topical Treatment 67 neointimal hyperplasia 67 calcaneal fractures 67 Inhibitory 67 treat benign prostatic 67 Benign Prostatic Hyperplasia BPH 67 Enlarged Prostate 67 Inhibits 67 Antiplatelet Therapy 67 Ascites 67 bullous 67 Cortical 67 Antiviral Therapy 67 ADPKD 67 Helps Predict 67 Vulvar 67 Erythropoietic 67 Anti Tumor 67 Refractory Angina 67 Myopathy 67 Shows Efficacy 67 Hemangiomas 67 Solid Tumors 67 Obstructive Sleep Apnea 67 Genes Predict 67 lichen planus 67 Oxidative Stress 67 Eluting Stent 67 Bronchopulmonary Dysplasia 67 Oral Cavity 67 Treatable 67 Reflux Disease 67 Bipolar Mania 67 Colon Polyps 67 REMINDER ORLive Presents 67 rFVIIa 67 Trigeminal Neuralgia 67 Gastrointestinal Stromal Tumors 67 hyperacute 67 Renal Anemia 67 Pulsatile 67 myoclonus 67 Patient Outcomes 67 Cholinesterase Inhibitors 67 Treatment Reduces 67 Transcription Factor 67 Gene Mutation Linked 67 Pivotal Trial 67 Coronary Angiography 67 Placebo Controlled Study 67 bacterial prostatitis 67 Cardiovascular Mortality 67 Left Ventricular Hypertrophy 67 Extracellular Matrix 67 Skin Lesions 67 platelet dysfunction 67 Monotherapy 67 NMDA Receptor 67 Ovarian Cancer Risk 67 Rare Genetic 67 Naive Patients 67 Meta Analysis 67 Neurogenesis 67 Retinopathy 67 Chronic Hepatitis C 67 Nocturia 67 Renal dysfunction 67 Attenuates 67 Acute Liver Failure 67 Cholesterol Levels SPARCL 67 myocardial infarction ventricular fibrillation 67 Stem Cell Treatment 67 Chemoradiation 67 Potentially Fatal 67 benign prostatic hypertrophy BPH 67 giant cell arteritis 67 Comorbid 67 JAK Inhibitor 67 Adjuvant Therapy 67 Signaling Pathways 67 Polymorphism 67 TNF Blockers 67 thyrotoxicosis 67 Claudication 67 paraneoplastic 67 Controlled Study 67 Hepatocellular 67 Node Positive 67 Transdermal Delivery 67 Novel Treatments 67 Degenerative Disc Disease 67 Postmenopausal 67 Survival Benefit 67 Gastroesophageal Reflux Disease 67 Keratitis 67 Ventilator Associated 67 Demonstrate Significant 67 T1DM 67 Well Tolerated 67 Drug Eluting 67 Systemic Lupus Erythematosus SLE 67 Alveolar 67 Randomized Clinical Trial 67 Treatment Resistant 67 Clinical Efficacy 67 Melasma 67 Demonstrates Sustained 67 Regenerative Cells 67 Bucindolol 67 Neovascular AMD 67 Neurodegenerative 67 paragangliomas 67 Uterine 67 Metastatic Pancreatic Cancer 67 Fibromyalgia Pain 67 LHON 67 Adjunctive Therapy 67 postoperative atrial fibrillation 67 Antigen Specific 67 fibrin deposition 67 Postmenopausal Osteoporosis 67 inducible nitric oxide synthase 67 Brain Aneurysms 67 Metastatic Cancer 67 Irritable Bowel Syndrome IBS 67 Symptom Relief 67 Endovascular Treatment 67 Spasticity 67 FDA Approves Drug 67 Diabetic neuropathy 67 Spinal Fluid 67 Antitumor 67 Post Operative 67 Gene Mutations 67 ANCA associated 67 Drug Candidate 67 Urinary Tract Infections 67 Therapeutic Efficacy 67 Gastroparesis 67 Emboli 67 Long Term Efficacy 67 Peritoneal 67 Venous thromboembolism 67 Hematological 67 Occlusion 67 monogenic 67 progressive dyspnea 67 anemia thrombocytopenia 67 included exfoliative dermatitis 67 Glioma 67 Randomized Trials 67 Study Evaluating 67 thrombocytosis 67 Bacterial Vaginosis 67 dermatologic reactions 67 Bisphosphonate 67 Immunotherapeutic 67 Immunomodulatory 67 Test Detects 67 Intra Arterial 67 Cancer Recurrence 67 Chronic Bronchitis 67 progressive neurodegenerative disorder 67 Initiate Clinical Trial 67 Erythema 67 Toxicities 67 Oxidative 67 Follicular Lymphoma 67 Prognostic Significance 67 Asthma COPD 67 Blood Pressure Drug 67 Lymph Node 67 Arterial Disease 67 Heterozygous Familial Hypercholesterolemia 67 intracranial hemorrhage ICH 67 Pivotal Clinical Trial 67 Smooth Muscle 67 Muscle Function 67 Epstein Barr Virus EBV 66 Brain Shrinkage 66 Beta Blockers 66 Atrophic 66 Chronic lymphocytic leukemia 66 hepatocellular 66 Radiation Dose 66 Hyperglycemia 66 Diabetic Macular Edema 66 Contrast Agent 66 autonomic dysfunction 66 Systemic lupus erythematosus 66 Pharmacologic 66 uricase 66 Contrast Agents 66 Beneficial Effects 66 Kidney Transplant Patients 66 Abdominal Pain 66 Improved Survival 66 Golimumab 66 Stent Thrombosis 66 Treatment Outcome 66 Liver Cirrhosis 66 Functional Outcomes 66 Generalized Anxiety Disorder 66 Lipoprotein 66 Phase 2b Trial 66 intracerebral hemorrhage ICH 66 Anti VEGF 66 gastric adenocarcinoma 66 Placebo Controlled Trial 66 neurological manifestations 66 Bone Marrow Cells 66 Statin Drugs 66 thyrotropin 66 invasive candidiasis 66 Multicenter Randomized 66 Treating Heart Failure 66 Gallbladder 66 Inactivation 66 Reduces Risk 66 Cervical Dysplasia 66 Mutational 66 Cardiovascular Outcomes 66 Aliskiren 66 unstable angina pectoris 66 J Am Coll 66 Posaconazole 66 Drug Combo 66 Impairs 66 Mimetics 66 Targeted Therapy 66 neovascularisation 66 Esophageal Cancer 66 Brainstem 66 Osteoporotic 66 Circulating Tumor Cells 66 Breast Density 66 Insulin Delivery 66 Peripheral Arterial Disease 66 Novel Therapeutic 66 Stress Incontinence 66 Inflammatory Disease 66 ADAMTS# 66 surgically resected 66 cerebral ischemia 66 anterior uveitis 66 Community Acquired Pneumonia 66 secondary hyperparathyroidism 66 Hormone Replacement 66 ischemic mitral regurgitation 66 Systemic lupus erythematosus SLE 66 keloid scarring 66 transcranial Doppler ultrasound 66 Obesity Linked 66 Left Ventricular Dysfunction 66 Less Invasive 66 Renal Cell Cancer 66 Differential Diagnosis 66 Chronic Insomnia 66 PsA 66 Nebulized 66 Randomized Controlled Trials 66 gastric carcinoma 66 colorectal adenoma 66 Homeostasis 66 cerebral infarctions 66 Lowers Blood Pressure 66 FDA Approvals 66 Physician Insights 66 Lung Cancers 66 chronic granulomatous disease 66 Genetic Marker 66 Viral Infections 66 ischemia reperfusion injury 66 Diabetic Kidney Disease 66 Blood Flow 66 II Clinical Trial 66 atherothrombotic 66 exocrine 66 hematological parameters 66 induce orthostatic hypotension 66 Upregulation 66 psoriatic arthritis PsA 66 Prostatitis 66 Parathyroid Hormone 66 Hip Fracture 66 Hepatitis C Genotype 66 Coronary Disease 66 Genetic Predisposition 66 PAOD 66 Proliferative 66 Valvular Heart Disease 66 Predict Response 66 Epithelial Cell 66 Trial Evaluating 66 EXJADE 66 experimentally induced 66 neurovascular diseases 66 Ejection Fraction 66 Phase IIb Trial 66 Colorectal Adenomas 66 Myocardial Infarction Study 66 Idiopathic pulmonary fibrosis 66 Bone Fracture 66 Clinical Trial Results 66 Chronic Fatigue Syndrome CFS 66 Chronic Lyme Disease 66 Coronary Artery Bypass Surgery 66 postoperative AF 66 thromboembolic disease 66 Lesion 66 Fallopian Tube 66 Protein Involved 66 Duodenal 66 Pegylated Liposomal Doxorubicin 66 Pulmonary Embolism PE 66 Menstrual Pain 66 serum phosphate 66 torsade de pointes 66 Ventricular 66 Embolism 66 Diagnostic Criteria 66 Paroxysmal Nocturnal Hemoglobinuria PNH 66 Synaptic Plasticity 66 Frontotemporal Dementia 66 Surgical Procedures 66 Metastatic 66 Bare Metal Stents 66 Lung Function 66 Cytotoxic T 66 Pulmonary hypertension 66 Glucocorticoids 66 Decompensated 66 Blood Vessels 66 Germline 66 Recombinant Human 66 Ribavirin causes 66 Peripheral arterial disease 66 Stem Cell Transplants 66 paroxysmal nocturnal hemoglobinuria 66 Smoking Linked 66 FDA Okays 66 Renal Failure 66 Anticancer Activity 66 myelofibrosis polycythemia vera 66 nonischemic 66 headache abdominal pain 66 Urethral 66 pancytopenia 66 etiologic 66 Pemphigus 66 ischemic complications 66 IDDM 66 silent ischemia 66 Percutaneous Tibial Nerve Stimulation 66 Tumor Necrosis Factor 66 Phase IIb Clinical Trial 66 Angina pectoris 66 Relapsed Refractory 66 HIV HCV coinfected 66 Aortic Aneurysms 66 Clinical Trial Data 66 Ileus 66 Squamous 66 Tumor Suppressor Gene 66 bronchial hyperresponsiveness 66 Neurophysiological 66 vWF 66 Contralateral 66 Aggressive Reduction 66 Rhabdomyolysis 66 breast endometrial 66 Hsp# Inhibitor 66 Virus Linked 66 Main Outcome Measure 66 Lung Transplants 66 gastrointestinal GI perforation 66 Remission Maintenance 66 Valve Replacement 66 Systemic Lupus Erythematosus 66 chronic myocardial ischemia 66 proliferative diabetic retinopathy 66 Myocarditis 66 Completes Patient Enrollment 66 urothelial carcinoma 66 experimental allergic encephalomyelitis 66 atypical Hemolytic Uremic Syndrome 66 mycosis fungoides 66 eccrine 66 Relapsed Multiple Myeloma 66 Autologous 66 Analytical Tool 66 Sclerosing 66 Chemokine Receptor 66 invasive aspergillosis 66 Non Responders 66 nonarteritic anterior ischemic optic 66 Reperfusion 66 Hemophilia B 66 Randomized Evaluation 66 Initiates Clinical Trial 66 Blocked Arteries 66 Nodules 66 Sjögren syndrome 66 Biliary 66 intrathoracic 66 abacavir Ziagen 66 Peginterferon Alfa 2a 66 Phase III Clinical Trial 66 Vascular Inflammation 66 Hemodynamic 66 Prolongs Life 66 Stent Restenosis 66 Hepatitis C Virus 66 Molecular Mechanism 66 Myeloid 66 Glucose Metabolism 66 Dose Escalation 66 Epstein Barr Virus 66 Diabetic Retinopathy 66 Hypertensive 66 intimal hyperplasia 66 Previously Treated 66 Lung Cancer Patients 66 Desvenlafaxine Succinate 66 Fecal Incontinence 66 Laryngeal Cancer 66 dominantly inherited 66 gastric cardia 66 Bosentan 66 seminomas 66 Zollinger Ellison Syndrome 66 Stomatitis 66 cause cardiac channelopathies 66 cardiac tamponade 66 Urate